Home
Products
Learn
About
Pricing
Log In
Back
VHL
Asset Logo

Vitasora Health Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿฉบ HEALTH CARE

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-10.71%
Annual Growth

5 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

3
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The company is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. The Wheezo is also used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children (two years and older).

๐Ÿ“ˆ Performance

Price History

-36.07%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.04

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in VHL

3

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in VHL

N/A
VHL investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

33%

50k - 100k

33%

Less than 50k

33%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

33%

35 - 90

67%
๐Ÿ™‹ Legal gender of investors

Female

67%

Male

33%

Pearlers who invest in VHL also invest in...

Respiri Limited

RSH

Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-07-14. The company is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. The Wheezo is also used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children (two years and older).

๐Ÿ™Œ Performance (5Yr p.a)

-10.57%

๐Ÿ“Š Share price

$0.03 AUD

๐Ÿฉบ HEALTH CARE

Find Out More

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

6.17%

๐Ÿ“Š Share price

$69.74 AUD

โ›ณ๏ธ DIVERSIFIED

๐ŸŒ GLOBAL

ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the โ€œIndexโ€), before taking into account fees and expenses.

๐Ÿ™Œ Performance (5Yr p.a)

6.42%

๐Ÿ“Š Share price

$11.32 AUD

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

RBTZ.AX was created on 2018-09-12 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. ๏ปฟRBTZ.AX aims to track the performance of an index (before fees and expenses) that includes global companies involved in the production or use of robotics and artificial intelligence (A.l.) products and services.

๐Ÿ™Œ Performance (5Yr p.a)

4.27%

๐Ÿ“Š Share price

$13.70 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.

๐Ÿ™Œ Performance (5Yr p.a)

16.91%

๐Ÿ“Š Share price

$15.28 AUD

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ‡ฆ๐Ÿ‡บ EX AUSTRALIA

Want more shares? Try these...

VHLCA

Compare
Add to watchlist